Yahoo
BSE - Delayed Quote INR

BDH Industries Limited (BDH.BO)

425.00 -1.15 (-0.27%)
At close: 3:25:46 PM GMT+5:30
Chart Range Bar
Loading chart for BDH.BO
  • Previous Close 426.15
  • Open 420.00
  • Bid 420.00 x --
  • Ask 425.00 x --
  • Day's Range 420.00 - 444.95
  • 52 Week Range 340.15 - 610.00
  • Volume 450
  • Avg. Volume 1,301
  • Market Cap (intraday) 2.447B
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 20.89
  • EPS (TTM) 20.34
  • Earnings Date (est.) --
  • Forward Dividend & Yield 5.00 (1.16%)
  • 1y Target Est --
  • Moby Rating Neutral

BDH Industries Limited engages in the manufacture and sale of therapeutic formulations for pharmaceuticals in India and Internationally. The company operates in two segments, Pharmaceuticals and Renewable Energy. It offers finished pharmaceuticals products, such as analgesic antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, antiulcers, and antivirals. The company also provides sedative, anxiolytic, antidepressants, calcium suppliments, cardiovascular, carminative, aromatic, corticosteroids, diuretics, electrolyte replinishers, expectorant, iron supplimentry, laxatives, local anesthetic, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, skin protective, skin smoothner, vitamins, pharmaceutical aid, and drugs acting on uterus products. In addition, it offers alkay-er tablets; morphine sulphate slow-release tablets; rilimorf; sulfasalazine delayed release tablets; indomethacin extended-release capsules; and Sildenafil citrate tablet. Further, the company owns two wind turbines with a capacity of 1.6 MW, located in Jaisalmer in Rajasthan. BDH Industries Limited was founded in 1935 and is based in Mumbai, India.

www.bdhind.com

95

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BDH.BO
0.78%
S&P BSE SENSEX (^BSESN)
4.95%

1-Year Return

BDH.BO
5.63%
S&P BSE SENSEX (^BSESN)
2.66%

3-Year Return

BDH.BO
120.41%
S&P BSE SENSEX (^BSESN)
24.66%

5-Year Return

BDH.BO
253.25%
S&P BSE SENSEX (^BSESN)
33.78%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY18
Revenue 69.77M
Earnings --
Profit Margin 0.00%

Q3

FY15

Q2

FY17

Q4

FY17

Q1

FY18

0
20M
40M
60M
80M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.74%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    997.09M

  • Net Income Avi to Common (ttm)

    117.1M

  • Diluted EPS (ttm)

    20.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    293.52M

  • Total Debt/Equity (mrq)

    2.62%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: